Insider Cluster (3 insiders) ·Filed Sep 1, 2026

CYTK

CYTOKINETICS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 3 insiders, $1.6M total
Actionable Insight • Neutral

No actionable signal from this insider cluster. The sales are trivial in size and consistent with option exercise and tax planning. Monitor for any upcoming corporate events (earnings, pipeline updates) that could provide context, but this filing alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
CYTK ▼ -7.69% at T+20d
NEUTRAL call ✗ call lost -7.69% · α vs SPY -7.80% · entry $71.40 → $65.91
Next anchor: T+60d in 8w
Entry anchored
Aug 31, 04:02 PM ET
via 1-min bar
T+1d
+0.74%
call +0.74% · α +0.30%
$71.93
settled 4w ago
T+5d
+3.80%
call +3.80% · α +3.71%
$74.11
settled 24d ago
T+20d
-7.69%
call -7.69% · α -7.80%
$65.91
settled 3d ago
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Three CYTK insiders (CEO, EVP, Director) sold a total of $1.59M in open-market shares over a 7-day window, primarily from option exercises and same-day sales. The total represents just 0.016% of the $9.9B market cap, making this a routine, non-informative cluster with no material signal for the stock.

Key Financial Metrics

Direction
selling
Total Value
$1.6M
Insiders
3

Key Facts

  • Total open-market insider sales: $1.59M (0.016% of $9.9B market cap)
  • CEO Blum sold 7,500 shares at $70.24 after exercising options at $10.60
  • EVP Callos sold 10,000 shares at $70.24 after exercising options at $0 and $23.26
  • Director Parshall sold 5,000 shares at $71.48 with no accompanying derivative exercise
  • All sales are small relative to company size and consistent with routine option-exercise liquidity

Financial Impact

Insider sales of $1.59M represent 0.016% of market cap — negligible economic impact

dilution

Risk Factors

  • Insider sales, while small, could be followed by larger sales if the stock appreciates further
  • No material risk identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (28 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYTK-1788332530884
32 reports for CYTK
Performance horizon
89% Hit rate 8 of 9 directional calls best @ T+20▲ +10.38%Mar 31, 2026
Filters
Rows
Reports for CYTK — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$69.31 $67.59▲ +2.48%▲ +4.59%$65.60 (+5.35%)
Sep 11, 2026
20d ago
Insider Cluster
NEUTRAL ★ 2/10
$72.45 $67.56▼ −6.75%▼ −6.86%$65.60 (−9.45%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.40 $74.11▲ +3.80%▲ +3.71%$65.60 (−8.12%)
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$71.40 $74.11▲ +3.80%▲ +3.71%$65.60 (−8.12%)
Aug 29, 2026
4w ago
Press Release
BULLISH ★ 7/10
$70.91 $75.35▲ +6.26%▲ +6.40%$65.60 (−7.49%)
Aug 28, 2026
5w ago
8-K
BULLISH ★ 7/10
$72.09 $72.72▲ +0.87%▲ +0.76%$65.60 (−9.00%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.42 $81.37▲ +1.18%▼ −2.44%$65.60 (−18.43%)
Jul 27, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.62 $77.13▼ −4.33%▼ −5.40%$65.60 (−18.63%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$80.74 $80.42▼ −0.40%▼ −0.77%$65.60 (−18.75%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.93 $79.11▼ −3.44%▼ −2.15%$65.60 (−19.93%)
Showing 10 of 32

US Market Status

Market Closed — Opens Mon (65h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 2, 2026